Ciladopa

Ciladopa (developmental code name AY-27,110) is a dopamine agonist with a similar chemical structure to dopamine. It was under investigation as an antiparkinsonian agent but was discontinued due to concerns of tumorogenesis in rodents.
Wikipedia contributors, "Ciladopa", Wikipedia, revision 1370505667, retrieved 20 November 2026, source, CC BY-SA 4.0.